When Wall Street first caught wind of the GLP-1 weight-loss drug boom—think medications like Ozempic and Wegovy—the initial reaction was panic for the fitness industry. The assumption was that if people could lose weight with a weekly injection, they would simply cancel their gym memberships and stay home.

The data is telling a completely different, and much more inspiring, story. Rather than replathe gym, GLP-1s are acting as a powerful catalyst for physical fitness.Here is a look at how these medications are actually reshaping fitness clubs, based on recent industry surveys, insights from local gym owners, and the latest clinical research.

Busting the Myth: Memberships Are Actually Up

According to a proprietary survey by William Blair, GLP-1 users are more likely to join fitness clubs after starting the medication.

Before taking the drugs, about 22% of respondents belonged to a fitness club (hovering near the national average). After starting treatment, that number jumped to 25%. The surge is even more dramatic among younger demographics: for users under 35, gym membership skyrocketed to nearly 50%.

Why the sudden motivation? It comes down to physical momentum.

• Increased mobility: 60% of GLP-1 users reported exercising more frequently. As the initial weight comes off, users report feeling less sluggish and more energetic.
• Joint relief: A local gym owner recently highlighted this exact phenomenon in Spectrum News, noting that as patients feel the physical pressure lift off their joints, their desire and ability to move increases, naturally driving them into fitness centers.

The Muscle Mass Mandate

While a surge in energy gets people in the door, there is a medical mandate keeping them there: preserving muscle mass.

Relying entirely on weight-loss medications without strength training is risky. As patients shed excess body fat, they often experience a corresponding decrease in muscle density. Health and fitness professionals are actively pivoting to address this, recommending a balanced, multi-pronged approach of cardio and strength training to ensure the weight lost is fat, not vital muscle tissue.

This clinical urgency is backed by recent data. A 2026 randomized controlled trial published in Sports Medicine looked directly at patients undergoing diet-induced weight loss. They compared groups using a GLP-1 receptor agonist alone versus those who combined the medication with a structured, moderate-to-vigorous exercise program. The results were striking:

• Medication alone isn’t enough: The group taking only the GLP-1 drug saw weight loss, but no improvement in physical functional performance or cardiorespiratory health.
• The combined advantage: Patients who combined the drug with exercise preserved their absolute muscle strength, increased their relative strength by 3.3%, and significantly improved their cardiorespiratory fitness (measured by peak oxygen consumption and faster stair-climbing times).

The Takeaway for Fitness Clubs

The narrative that GLP-1s will cannibalize the fitness industry is officially dead. These medications are removing the initial, often overwhelming physical barriers to exercise—getting the ball rolling for millions of people who previously felt too sluggish or joint-compromised to work out.

For fitness clubs, this is a massive tailwind. The gyms that will thrive are the ones leaning into this demographic by offering welcoming environments and targeted strength-training programs designed specifically to help GLP-1 users rebuild and preserve their muscle density.